Manuela Bartolini

10.0k total citations · 1 hit paper
158 papers, 8.2k citations indexed

About

Manuela Bartolini is a scholar working on Pharmacology, Computational Theory and Mathematics and Physiology. According to data from OpenAlex, Manuela Bartolini has authored 158 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Pharmacology, 83 papers in Computational Theory and Mathematics and 53 papers in Physiology. Recurrent topics in Manuela Bartolini's work include Cholinesterase and Neurodegenerative Diseases (122 papers), Computational Drug Discovery Methods (83 papers) and Alzheimer's disease research and treatments (52 papers). Manuela Bartolini is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (122 papers), Computational Drug Discovery Methods (83 papers) and Alzheimer's disease research and treatments (52 papers). Manuela Bartolini collaborates with scholars based in Italy, Spain and United States. Manuela Bartolini's co-authors include Vincenza Andrisano, María Laura Bolognesi, Andrea Cavalli, Carlo Melchiorre, Vanni Cavrini, Carlo Bertucci, Michela Rosini, Maurizio Recanatini, Angela Rampa and Federica Belluti and has published in prestigious journals such as Angewandte Chemie International Edition, Hepatology and Biochemistry.

In The Last Decade

Manuela Bartolini

156 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies

2003 509 citations Manuela Bartolini, Vincenza Andrisano et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manuela Bartolini Italy	52	5.6k	3.9k	2.9k	2.4k	2.2k	158	8.2k
María Laura Bolognesi Italy	50	4.4k 0.8×	3.2k 0.8×	3.1k 1.1×	3.1k 1.3×	2.1k 1.0×	200	9.2k
Vincenza Andrisano Italy	54	5.9k 1.1×	4.0k 1.0×	3.1k 1.1×	2.9k 1.2×	2.4k 1.1×	242	10.1k
José Marco‐Contelles Spain	51	3.7k 0.7×	2.1k 0.5×	6.6k 2.3×	2.2k 0.9×	1.2k 0.6×	323	9.8k
Maurizio Recanatini Italy	50	2.7k 0.5×	2.8k 0.7×	2.3k 0.8×	3.5k 1.4×	860 0.4×	168	7.9k
Carlo Melchiorre Italy	40	3.3k 0.6×	2.1k 0.6×	2.1k 0.7×	2.8k 1.2×	1.5k 0.7×	178	6.5k
Jan Korábečný Czechia	38	2.7k 0.5×	1.6k 0.4×	1.7k 0.6×	1.3k 0.5×	653 0.3×	175	4.5k
Michela Rosini Italy	36	3.0k 0.5×	1.9k 0.5×	1.6k 0.6×	1.6k 0.7×	1.2k 0.6×	94	4.9k
Anna Minarini Italy	34	2.5k 0.4×	1.6k 0.4×	1.4k 0.5×	1.8k 0.7×	969 0.4×	112	4.4k
Angelo Carotti Italy	47	2.1k 0.4×	1.6k 0.4×	3.3k 1.1×	2.3k 1.0×	441 0.2×	196	7.2k
Barbara Malawska Poland	30	1.8k 0.3×	1.3k 0.3×	1.3k 0.5×	1.2k 0.5×	1.0k 0.5×	141	3.8k

Countries citing papers authored by Manuela Bartolini

Since Specialization

Citations

This map shows the geographic impact of Manuela Bartolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Bartolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Bartolini more than expected).

Fields of papers citing papers by Manuela Bartolini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Bartolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Bartolini. The network helps show where Manuela Bartolini may publish in the future.

Co-authorship network of co-authors of Manuela Bartolini

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Bartolini. A scholar is included among the top collaborators of Manuela Bartolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Bartolini. Manuela Bartolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Airoldi, Mario, Laura Giordano, Manuela Bartolini, et al.. (2024). 456P Correlation between pathological complete response (pCR) and survival outcomes in patients with resectable esophageal (EC) or gastroesophageal junction cancer (GEJC): A large, real-world, single-center cohort analysis. Annals of Oncology. 35. S182–S183.

Navacchia, Maria Luisa, Manuela Bartolini, Marina Naldi, et al.. (2024). HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy–an in vitro exploration. Frontiers in Chemistry. 12. 1378233–1378233. 2 indexed citations

Bartolini, Manuela, María Laura Bolognesi, Mümin Alper Erdoğan, et al.. (2024). Novel multifunctional tacrine–donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies. Archiv der Pharmazie. 357(7). e2300575–e2300575. 2 indexed citations

Baldassarre, Maurizio, Daniele Tedesco, Irene Capelli, et al.. (2024). Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus. International Journal of Molecular Sciences. 25(6). 3168–3168. 2 indexed citations

Giordani, Barbara, et al.. (2023). Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms. Microbial Cell Factories. 22(1). 45–45. 19 indexed citations

Gonçalves, Ana Elisa, Claudia Albertini, Jana Janočková, et al.. (2022). Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer’s Disease. ACS Chemical Neuroscience. 13(23). 3314–3329. 12 indexed citations

Bisi, Alessandra, Alessandra Feoli, Alfonso Trezza, et al.. (2022). Targeting neuronal calcium channels and GSK3β for Alzheimer’s disease with naturally-inspired Diels-Alder adducts. Bioorganic Chemistry. 129. 106152–106152. 7 indexed citations

Albertini, Claudia, Marina Naldi, Sabrina Petralla, et al.. (2021). From Combinations to Single-Molecule Polypharmacology—Cromolyn-Ibuprofen Conjugates for Alzheimer’s Disease. Molecules. 26(4). 1112–1112. 8 indexed citations

Górecki, Lukáš, Elisa Uliassi, Manuela Bartolini, et al.. (2021). Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer’s Disease. ACS Chemical Neuroscience. 12(9). 1698–1715. 19 indexed citations

10.

Montanari, Serena, Marco Allarà, Laura Scalvini, et al.. (2021). New Coumarin Derivatives as Cholinergic and Cannabinoid System Modulators. Molecules. 26(11). 3254–3254. 12 indexed citations

11.

Baldassarre, Maurizio, Marina Naldi, Giacomo Zaccherini, et al.. (2021). Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications. Hepatology. 74(4). 2058–2073. 50 indexed citations

12.

Scheiner, Matthias, Sandra Gunesch, Matthias Hoffmann, et al.. (2019). Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo. Journal of Medicinal Chemistry. 62(20). 9078–9102. 39 indexed citations

13.

Oukoloff, Killian, Nicolas Coquelle, Manuela Bartolini, et al.. (2019). Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3. European Journal of Medicinal Chemistry. 168. 58–77. 56 indexed citations

14.

Naldi, Marina, Maurizio Baldassarre, Marco Domenicali, Manuela Bartolini, & Paolo Caraceni. (2017). Structural and functional integrity of human serum albumin: Analytical approaches and clinical relevance in patients with liver cirrhosis. Journal of Pharmaceutical and Biomedical Analysis. 144. 138–153. 47 indexed citations

15.

Uliassi, Elisa, Jan Korábečný, Ondřej Soukup, et al.. (2016). Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease. European Journal of Medicinal Chemistry. 127. 250–262. 85 indexed citations

16.

Belluti, Federica, Angela De Simone, Andrea Tarozzi, et al.. (2014). Fluorinated benzophenone derivatives: Balanced multipotent agents for Alzheimer's disease. European Journal of Medicinal Chemistry. 78. 157–166. 20 indexed citations

17.

Brogi, Simone, Stefania Butini, Samuele Maramai, et al.. (2014). Disease‐Modifying Anti‐Alzheimer's Drugs: Inhibitors of Human Cholinesterases Interfering with β‐Amyloid Aggregation. CNS Neuroscience & Therapeutics. 20(7). 624–632. 46 indexed citations

18.

Staderini, Matteo, Suzana Aulić, Manuela Bartolini, et al.. (2012). A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer’s and Prion Diseases. ACS Medicinal Chemistry Letters. 4(2). 225–229. 52 indexed citations

19.

Rizzo, Stefano, Alessandra Bisi, Manuela Bartolini, et al.. (2011). Multi-target strategy to address Alzheimer’s disease: Design, synthesis and biological evaluation of new tacrine-based dimers. European Journal of Medicinal Chemistry. 46(9). 4336–4343. 34 indexed citations

20.

Bolognesi, María Laura, Andrea Cavalli, Vincenza Andrisano, et al.. (2003). Design, synthesis and biological evaluation of ambenonium derivatives as AChE inhibitors. Il Farmaco. 58(9). 917–928. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact